FOXD2 and gastric cancer: In gastric cancer (GC), upregulation of FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EPHB3 via recruiting EZH2 and LSD1, leading to H3K27 methylation and H3K4 demethylation, respectively [39].